Beta Bionics, Inc.BBNXEarnings & Financial Report
Nasdaq
NextMar 31, 2026
BBNX Q3 2025 Key Financial Metrics
Revenue
$27.3M
Gross Profit
$15.1M
Operating Profit
$-17.0M
Net Profit
$-14.2M
Gross Margin
55.5%
Operating Margin
-62.5%
Net Margin
-52.1%
YoY Growth
63.1%
EPS
$-0.33
Financial Flow
Beta Bionics, Inc. Q3 2025 Financial Summary
Beta Bionics, Inc. reported revenue of $27.3M for Q3 2025, with a net profit of $-14.2M (-52.1% margin). Cost of goods sold was $12.1M, operating expenses totaled $32.2M.
Key Financial Metrics
| Total Revenue | $27.3M |
|---|---|
| Net Profit | $-14.2M |
| Gross Margin | 55.5% |
| Operating Margin | -62.5% |
| Report Period | Q3 2025 |
Beta Bionics, Inc. Annual Revenue by Year
Beta Bionics, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $65.1M).
| Year | Annual Revenue |
|---|---|
| 2024 | $65.1M |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | $12.9M | $15.0M | $16.7M | $20.4M | $17.6M | $23.2M | $27.3M |
| YoY Growth | N/A | N/A | N/A | N/A | 36.4% | 54.4% | 63.1% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|
| Assets | N/A | N/A | N/A | $149.6M | $338.0M | $330.0M | $330.0M |
| Liabilities | N/A | N/A | N/A | $73.6M | $24.3M | $28.3M | $35.3M |
| Equity | $-214.3M | $-221.2M | $-228.8M | $-245.4M | $313.8M | $301.6M | $294.8M |
Cash Flow
| Q1 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|
| Operating CF | $-12.1M | $-20.0M | $-13.6M | $-8.7M |